During 2020, the therapeutic monoclonal antibody PD-1/PD-L1 mAb had a share of 18 percent of clinical drug trials in the oncology pipeline. This statistic shows the share of clinical drug trials in the oncology pipeline worldwide in 2020, by key technology.
Share of clinical trials in the oncology pipeline worldwide in 2020, by key technology
among active trials phase 2-3 for 56 pharmaceutical companies
Supplementary notes
* Includes key technologies with a share of 2 percent or less of the pipeline: RNA polymerase II inhibitor, angiogenesis inhibitor, c-MET inhibitor, CDK inhibitor, C-RET inhibitor, BCR-ABL inhibitor, anti-CD38 Ab, PI3K Inhibitor, proteasome inhibitor, multikinase inhibitor, ATR protein inhibitors, nectin-4 targeted ADC, and MEK inhibitor
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
EFPIA. (February 22, 2021). Share of clinical trials in the oncology pipeline worldwide in 2020, by key technology [Graph]. In Statista. Retrieved December 19, 2024, from https://www.statista.com/statistics/1249138/oncology-pipeline-by-key-technologies-worldwide/
EFPIA. "Share of clinical trials in the oncology pipeline worldwide in 2020, by key technology." Chart. February 22, 2021. Statista. Accessed December 19, 2024. https://www.statista.com/statistics/1249138/oncology-pipeline-by-key-technologies-worldwide/
EFPIA. (2021). Share of clinical trials in the oncology pipeline worldwide in 2020, by key technology. Statista. Statista Inc.. Accessed: December 19, 2024. https://www.statista.com/statistics/1249138/oncology-pipeline-by-key-technologies-worldwide/
EFPIA. "Share of Clinical Trials in The Oncology Pipeline Worldwide in 2020, by Key Technology." Statista, Statista Inc., 22 Feb 2021, https://www.statista.com/statistics/1249138/oncology-pipeline-by-key-technologies-worldwide/
EFPIA, Share of clinical trials in the oncology pipeline worldwide in 2020, by key technology Statista, https://www.statista.com/statistics/1249138/oncology-pipeline-by-key-technologies-worldwide/ (last visited December 19, 2024)
Share of clinical trials in the oncology pipeline worldwide in 2020, by key technology [Graph], EFPIA, February 22, 2021. [Online]. Available: https://www.statista.com/statistics/1249138/oncology-pipeline-by-key-technologies-worldwide/
